Financial Personal
Tris Pharma Launches Digital Health Business to Develop and Commercialize Digital Products for ADHD
– Tris Digital Health enters into licensing agreement with Braingaze to develop and commercialize first-in-class, AI-enhanced technology that offers healthcare professionals an objective tool to improve accuracy of ADHD diagnosis – – Tris will conduc
MONMOUTH JUNCTION, N.J. -- Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and neurological disorders, has entered into a licensing agreement with Braingaze Ltd. (Braingaze) and launched its new business, Tris Digital Health, which will focus on the development and commercialization of digital diagnostic and therapeutic products for neurological health conditions. Read More
Related
Share this page
Guest Posts by Easy Branches